B2DB — Who said what, where, and when

Julian Dye

Dr/CEO, Oxartis Limited

Oxartis is developing affordable tissue-regenerative scaffold technology from Oxford University. The lead product, ProMatrix BioDerm, will transform outcomes for millions of patients by accelerating skin reconstruction while preventing scarring.

Events Julian Dye has spoken at